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A new type of mitogenic factor, termed MF. has been found in the culture supernatant of Strrpfococcus pyogenes and its N-terminal amino acid 
sequence has been determined. On the basis of this sequence, an S pyogenes gene encoding MF was cloned and its nucleotide sequence was 
determined. The MF gene includes a long, open reading frame with 813 nucleotides capable of encoding the MF precursor protein with 271 amino 
acids. Removal of the putative 43 residues as a signal peptide results in the mature MF protein with 228 amino acids. The molecular mass of the 
mature MF is calculated as 25,363 which is consistent with the previously determined value of 25,370 for MF secreted from S. pyogenes. Neither 
nucleotide nor amino acid sequence homology was found between the mature MF and other streptococcal pyrogenic exotoxms, such as SPE A. 
SPE B and SPE C. The mature MF was recombinantly overexpressed as a fusion protein with glutathione S-transferase m Escherlchia coli. The 
recombinant protein showed mitogenic activity in rabbit peripheral blood lymphocytes and immunoreactivity with the rabbit antiserum raised 
against the secreted MF from S pyogenes. These data indicate that a unique gene encodmg MF was cloned from S. pyogenes. 
Streptococcus; Mitogenic factor, Molecular cloning; Nucleotide sequence; Expression; Streptococcal pyrogenic exotoxin 
1. INTRODUCTION 
Three serologically distinct streptococcal pyrogenic 
exotoxins (SPEs), SPE A, SPE B and SPE C. have so 
far been reported. Their genes were cloned and their 
nucleotide sequences have already been defined [l-4]. 
These toxins have several biological activities such as 
pyrogenicity, mitogenicity, enhancement of susceptibil- 
ity to endotoxic shock, suppression of IgM and en- 
hancement of IgG production [5]. Recent studies have 
shown that these streptococcal pyrogenic exotoxins and 
certain enterotoxins from Staphylococcus aureu~ com- 
prise a family of superantigens [6-81, defined as bifunc- 
tional molecules binding to MHC class II structure and 
activating T cells expressing appropriate V, segments of 
the T cell receptor [g-12]. 
During the biochemical studies on SPEs, we found a 
new type of mitogenic factor, termed MF, as previously 
reported [ 131. In the present paper, we cloned the gene 
encoding MF and characterized it. It is a novel gene and 
has no homology to known SPE genes. Using the cloned 
gene, the overexpression of the recombinant MF was 
achieved and its mitogenic activity and immunoreactiv- 
ity with the rabbit antiserum to the secreted MF from 
S. pyogenes were determined. 
*Corresponding author 2.3. Rrstrictlon enzyme mapping by Southern analysts 
The nucleotide sequence data reported in this paper will appear in the 
DDBJ, EMBL and GenBank Nucleotide Sequence Databases with the 
following accession number D13428. 
Genomic DNA of the S pyogenes strain NY-5 was digested with 
various restriction enzymes and electrophoresed on a 0.8% agarose 
gel. The DNA in the gel was denatured and reneutrahzed followed by 
transfer to a nylon membrane (Hybond N+, Amersham. Bucking- 
2. MATERIALS AND METHODS 
2.1. Bacterrul strains 
The S. pyogenes strain NY-5 kindly provided by T. Nakahara 
(Saitama College of Health, Urawa, Japan) was used. 
2.2. Gene detection by PCR 
Three ohgonucleotide primers for the polymerase chain reaction 
(PCR) were designed on the basis of the deduced nucleotide sequence 
from the determmed amino acid sequence of the N-terminal portion 
of MF [13] (Fig. 1A) and were synthesized as follows: primer 1, 
5’-tcgaattcCA(A/G)ACNCA(A/G)GT-3’ (16 mixtures of 19-mer cor- 
responding to amino acids 14 of MF); primer 2. 5’-caaagcttA(G1 
A)NGC(T/C)TC(A/G)TT-3’ (32 mixtures of 19-mer for complemen- 
tary strand corresponding to amino acids 19-22 of MF); primer 3, 
5’-tcgaattcAA(T/C)GA(T/C)GTNGT-3’ (16 mixtures of 19-mer corre- 
sponding to amino acids 6-9 of MF). The lower-case letters in these 
primer sequences indicate the sequence of the tag with the restriction 
enzyme recognition sequences, EcoRI for primers 1 and 3 and HlndIII 
for primer 2, respectively. Genomic DNAs from bacteria were pre- 
pared according to the modified SDS-phenol method as already de- 
scribed [14]. PCR was carried out for 50 cycles m a 50 ~1 reaction 
mixture containing 200 PM dNTPs, 0.1 ng of genomic DNA and 1.25 
units AmpliTaq DNA polymerase (Perkin-Elmer Cetus. CA, USA) 
usmg a thermal sequencer (Iwaki Glass Co. Ltd., Japan). The primer 
concentration was 1 PM and the temperature cycles were as follows: 
94°C for 30 s, 37°C for 60 s and 72°C for 10 s. The amplified products 
were fractionated by agarose gel electrophoresis and determined by 
staining with ethidium bromide (0.5 &ml) The DNA fragment was 
directly sequenced according to the dideoxy chain termination proce- 
dure using a Sequenase Ver 2.0 (United States Biochemical, OH, 
USA). 
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hamshire. UK). Hybridization was performed in a hybridization solu- 
tion (6 x SSC. 5 x Denhardt’s. 30% (v/v) formamide, 0.5% (w/v) SDS, 
0.5 mg/ml heparin) at 42°C for 16 h. A denatured 5’-3’P-end- labeled 
PCR product from the MF gene was used as a probe. Exposure to 
X-ray film (Eastman Kodak Co., NY, USA) was done with an inten- 
sifying screen. 
2 4 Gene cloning and DNA sequencing 
The genomic DNA of S. progefres was completely digested with 
both PstI and H~~zdIII and electrophoresed on a 0 8% agarose gel. The 
DNA fragments were extracted from the gel containing the MF gene 
fragment. which was expected to be about 2.1 kb in size, and ligated 
into a vector pBluescript SK(+) (Stratagene, CA, USA). E coliJM109 
cells were transformed by the ligation mixture. The clone, which con- 
tamed the plasmid capable of encoding MF, was identified by screen- 
mg with the colony hybridization method using the PCR product 
DNA amplified from the MF gene as a probe. In order to determine 
the whole sequence of the MF gene, PCR was performed with either 
the T7 primer or T3 primer, which is located on the T7 or T3 promoter 
region in the vector, respectively, and with either the primer 4 or 5 
(Fig. IA). PCR with T3 primer and primer 5 or with primer 4 and T7 
primer gave the 1.1 kb or 1 2 kb amplified DNA, respectively. These 
amplified products were directly sequenced by a dsDNA Cycle Se- 
quencing System (BRL, MD. USA). 
2 5. Overexpression and purification of the recombmant MF protein 
The DNA fragment comprismg the coding region for the mature 
MF protein was amplified by PCR with primers 5’- 
ctggatccCAAACACAGGTCT-3’ (21-mer with a BarrlHI recognition 
sequence) and 5’-gcgaattcCTAGCCTTTTGGTAT-3’ (23-mer with an 
EcoRl recognition sequence). This fragment was ligated with a pGEX- 
2T expression vector (Pharmacta LKB Biotechnology AB, Uppsala, 
Sweden) to obtain the plasmid capable of expressing an MF protein 
as a fusion protein with glutathione S-transferase (GST-MF). E coli 
cells were transformed by the ligation mixture and several transfor- 
mants were isolated. The transformant was cultured with Terrific 
broth [15] at 37°C overmght with shaking. The expression of the 
GST-MF fusion protein was induced with 5 mM IPTG during the last 
3 h of the culture. The cells were harvested by centrifugation and were 
disrupted by sonication. The bacterial lysates were applied to a pre- 
packed-glutathione Sepharose 4B column (Pharmacia LKB Btotech- 
nology, Uppsala, Sweden). After washing the column with a phos- 
phate-buffered saline (PBS), the bound material was eluted with elu- 
tion buffer (5 mM glutathione in 50 mM Tris-HCl. pH 8.0). The purity 
of the fusion protein was analyzed on SDS-polyacrylamide slab gel 
electrophoresis (SDS-PAGE) as described by Laemmh [16] in a 12% 
acrylamtde gel, followed by staining for protem with a Quick CBB or 
a Silver stain kit (Wako Pure Chemical Industries, Ltd., Osaka, 
Japan). The GST-MF fusion protein was cleaved at the Junction 
region by digesting with human thrombm (Sigma Chemical Co . MO, 
USA) and separated into two molecules of GST and MF 
2.6. Preparation oJanti-A4F antiserum 
The MF protein was purified from the culture supernatant of the 
S pyogenes strain NY-5 as previously described [13]. The purified 
protein solution (10 pug/l ml) was emulsified with an equal volume of 
Freund’s complete adJuvant (Dtfco Laboratories, MI. USA) and in- 
Jetted mto multiple sites in the skin of a rabbit. Three weeks later, the 
emulsion of 10 pug of the same MF protein with an equal volume of 
a mixture of Freund’s complete and incomplete adjuvant was intra- 
dermally injected. Two more intradermal injections with the emulsion 
of MF with Freund’s incomplete adjuvant were given at 3 week mter- 
vals. and 4 weeks after the final mjection. the antiserum was obtamed. 
2.7. Double gel immunodiffusion and Western blot anulyses 
Micro-double gel immunodiffusion analysts was carried out as de- 
scribed by Ouchterlony [17]. Western blot analysts was performed as 
follows: the fusion protein was electrophoresed on an SDS-poly- 
acrylamide gel and transferred to a polyvinyhdene difluoride (PVDF) 
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membrane (Trans-Blot Transfer Medium; BtoRad Laboratories, CA, 
USA) The membrane was treated with the rabbit anti-MF antiserum 
at l:l.OOO dilutton in a blocking solution (10% Block-Ace in PBS: 
Dainippon Pharmaceutical Co., Ltd.. Osaka, Japan) at room temper- 
ature for 30 min. A Vectastain ABC Kit (Vector Laboratories Inc., 
CA, USA) and a Konica Immunostainmg-HRP Kit (IS-SOB; Komca 
Co. Ltd., Tokyo, Japan) were employed for detection of the MF 
protein. 
2.8. Asscr) for mltogemc actwq 
Mitogemc activity m rabbit peripheral blood lymphocytes was as- 
sayed as previously described [13]. [methyl-‘HjThymidine (185 GBq/ 
mmol; Amersham, England) was used. Concanavalin A (Seikagaku 
Kogyo Co. Ltd., Tokyo. Japan) was used as a positive control for the 
assay. 
3. RESULTS 
3.1. Detection ana’ cloning of the MF gene 
As already reported [13], the sequence of the first 21 
N-terminal amino acids of MF secreted from 5’. pyo- 
genes has been determined. In addition to the sequence, 
as shown in Fig. lA, two additional residues, Leu-Ala 
corresponding to the 22nd and 23rd amino acids of the 
N-terminal of MF, were identified by further amino 
acid sequencing. To isolate the genomic region encod- 
ing this N-terminal of MF by PCR, the three degenerate 
B C 
pr,mers 3i2 mmers4/5 
Fig. 1. Determination of the presence of the S. p.vogenes MF gene by 
PCR. (A) The N-terminal amino acid sequence of MF. its predicted 
nucleottde sequence and the location of PCR primers. First row: the 
defined N-terminal ammo acid sequence of the native MF protein 
secreted from S pyopenes. Second row: its predicted nucleotide se- 
quences. Alternative nucleotides are represented by N for the four 
nucleotides or addition of a nucleotide under the first line. Third row. 
the determined nucleotide sequence of the DNA fragment amphtied 
from the S. pyogenes DNA by PCR with primers 1 and 2. Primers: 
location of each prrmer shown by an arrow. Primers 1, 3, and 4 are 
5’-primers and primers 2 and 5 are 3’-primers. Fully degenerated 
primers 1. 2, and 3 contain all sequences enabling one to deduce from 
each amino acid sequence. The sequence of primers 4 and 5 are de- 
scribed m the text. The sequence of the 3’-terminal 7 or 5 nucleotides 
of primers 4 or 5, respectively, was designed based on the authentic 
sequence depicted m the third row. (B, C) Determination of the PCR 
products by agarose gel electrophoresis. Genomic DNAs from four 
S. pyogenes strains. NY-5 (N) and others (A. B, C). and the E roll 
stram MC1061 (E) were amplified by PCR with primers 1 and 2 
(Primers l/2), 3 and 2 (Primers 3/2) and 4 and 5 (Primers 4/5) and then 
expected, amplified bands of 81 bp, 66 bp and 71 bp size m length are 
mdicated by arrows, respectively. M: WaeIII digested $X174 DNA 
size markers. 
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Fig. 2. Southern analysis and the restriction map of the S pyogenes 
DNA fragment bearing the MF gene (A) Southern blot autoradi- 
ogram. Genomic DNA extracted from the S. pyogenes strain NY-5 
was digested singly or doubly with restriction enzymes indicated on 
the top of each lane. Enzymes EcoRI (E), KpnI (K), Hind111 (H), f’stI 
(P), and Sau3AI (S) were used. The digested DNAs were fractionated 
by agarose gel electrophoresis and transferred to a nylon filter, fol- 
lowed by hybridization with the probe of the “P end-labeled 71 bp MF 
DNA fragment amplified from the S pyogenes DNA by PCR with 
primers 4 and 5. The DNA molecular size markers (EcoT141 digested 
lambda phage DNA, Takara Shuzoh Co., Ltd., Kyoto, Japan) are 
shown at the right. (B) Restriction map of the MF gene. A long 
horizontal line Indicates the genomic DNA involvmg the region of the 
MF gene. The location of the MF gene defined by nucleotide sequence 
analysis is indicated by a thick horizontal bar. Each restriction enzyme 
site IS shown by a vertical bar with an abbreviated symbol for each 
restriction enzyme as already mentioned. A thin horizontal bar indi- 
cates the 1 kb size control. 
primers 1, 2, and 3 were designed and synthesized as 
described in Section 2 and Fig. IA. PCR with these 
primers was done with S. pyogenes and E. coli genomic 
DNAs as templates (Fig. lB,C). When used with prim- 
ers 1 and 2, an expected 81 bp DNA band was amplified 
from all DNAs of the four S. pyogenes strains used but 
not from the control E. cofi DNA (Fig. 1B). Addition- 
ally, several unexpected DNA bands were also ampli- 
fied from DNAs of both S. pyogenes and E. coli, how- 
ever these bands appeared to be non-specific. When 
used with primers 3 and 2, an expected 66 bp DNA 
band was amplified from all DNAs of the four S. pyo- 
genes strains but not from the control E. coli DNA. 
Thus, these expected DNA products were directly se- 
quenced. The nucleotide sequence data appeared to 
show that the sequences of these bands amplified from 
the four S. pyogenes strains were identical and one of 
three amino acid sequences deduced from its nucleotide 
sequence was consistent with the defined amino acid 
sequence of the N-terminal of MF (Fig. 1A). This evi- 
dence suggests that these expected PCR products were 
derived from the authentic MF gene of S. pyogenes and 
supports the fact that E. coli does not contain the MF 
gene. Based on this nucleotide sequence, a new set of 
primers 4 (S-tcgaattcCAGGTCTCAAAT-3’, capital 
letters indicating the nucleotide sequence from the MF 
gene sequence determined and lower case letters indicat- 
ing the sequence of the rag with the EcoRI recognition 
site) and 5 (S-CtaagcttCCTCGTTTAGGT-3’, capital 
letters indicating the nucleotide sequence from the MF 
gene sequence determined and lower case letters indicat- 
ing the sequence of the tag with the complementary 
sequence of the Hind11 recognition site) was designed 
(Fig. 1A) and synthesized. PCR with primers 4 and 5 
gave the expected 71 bp DNA band from DNAs of all 
four S. pyogenes strains but not from the control E. coli 
DNA on an agarose gel (Fig. lC), suggesting that these 
expected PCR products are derived from the S. pyo- 
genes MF gene and again supporting the presence of the 
MF gene in S. pyogenes but not in E. coli. 
In order to determine the entire MF genomic organi- 
zation of S. pyogenes, Southern analysis with this 71 bp 
PCR product DNA as a probe was performed. From 
the results (Fig. 2A), The restriction enzyme map of the 
genome carrying the MF gene was postulated as shown 
in Fig. 2B. It shows that the MF gene exists on a 1 .l kb 
Sau3AIISau3AI DNA fragment and a 2.1 kb PstI- 
Hind111 fragment includes this Sau3AI-Sau3AI frag- 
ment. Therefore, the 2.1 kb PstI-Hind111 fragment was 
cloned into the pBluescript vector and its nucleotide 
sequence was determined by direct-sequencing as de- 
scribed in Section 2. The sequence data (data not 
shown) indicated that the fragment is 2,099 bp in length 
and involves one long, open reading frame with 813 
A 
1 
P 
1 44 271 (aa) 
B 
Fig. 3. Genomic structure of the MF gene and the deduced amino acid 
sequence of MF. (A) Diagram of a PstIIHindIII fragment containing 
the open reading frame of MF. The open and shaded boxes represent 
the regions of the mature MF protein with 228 amino acids and the 
signal peptide with 43 amino acids. respectively. The numbers of the 
nucleotide and the amino acid are started from the pst1 recognition 
site and the initiation amino acid site, respectively. P, PsrI; S, Sau3AI; 
H. HindIII. (B) Predicted amino acid sequence of the precursor MF 
protein. The nucleotide sequence data of the MF gene will appear in 
the DDBJ, EMBL and GenBank Nucleotide Sequence Databases 
(accession number D13428). The ammo acid sequence identical to that 
of the N-terminal region of the native MF protein secreted from S. 
pq’ogenes is indicated by underlining. 
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nucleotides, which has the capacity to encode a pol- 
ypeptide with 271 amino acids, as shown in Fig. 3A. The 
identical amino acid sequence to the N-terminal amino 
acid sequence of the native MF protein secreted from 
S. pvogenes was found in that of this polypeptide from 
positions 44 to 64 (Fig. 3B), suggesting that the pol- 
ypeptide is a precursor protein of MF and that removal 
of the putative 43 residues as a signal peptide results in 
the mature MF protein with 228 residues. The molecu- 
lar mass of the mature MF is calculated as 25.363, 
which is exactly consistent with the previously described 
value (25,370) for the secreted MF determined by the 
measurement of ion-spray mass spectra [13]. Its amino 
acid composition calculated from the deduced amino 
acid sequence is almost the same as that of MF secreted 
from S. pyogenes (Table I). From these results, we con- 
cluded that the clone is from the authentic S. pyogenes 
MF gene. 
Comparison of the deduced MF precursor protein 
sequence with sequences in the GenBank Databases re- 
vealed no significant homology with known SPEs, such 
as SPE A, SPE B, and SPE C, or with other known 
proteins. This suggests that the MF gene cloned in this 
study is unique. 
Table I 
Comparison of amino acid composition between the native and the 
predicted mature MF ammo acid sequences 
Amino acid 
Predicted value* 
Mel% Count 
Determmed value** 
Mel% 
GUY 
Ala 
Val 
Leu 
Ile 
Ser 
Thr 
Cys 
Met 
Asp 
Asn 
AsplAsn 
Glu 
Gln 
Glu/Gln 
Arg 
Lys 
His 
Phe 
Tyr 
Trp 
Pro 
9.65 
7.89 
6.58 
7.89 
3 51 
5.26 
8.77 
0.00 
0.88 
5.26 
9.65 
4.39 
4.82 
5.26 
4.39 
1.32 
1.75 
7.02 
2.19 
3.51 
22 10.4 
18 84 
15 6.9 
18 8.4 
8 3.7 
12 4.8 
20 8.0 
0 ND 
2 0.0 
2 
22 
16.1 
10 
11 
9.8 
12 5.4 
10 4.8 
3 1.6 
4 2.1 
16 5.8 
5 ND 
8 3.7 
*The values were calculated from the amino acid sequence of the 
mature formed MF protem deduced from the MF gene cloned. 
**The values obtained from the native MF protein secreted from the 
S. pyogenes strain NY-5 as previously described [13]. 
ND, not determined. 
A B 
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Fig. 4. Characterization of the recombinant MF protein by SDS- 
PAGE and Western blot analyses. Lane 1. prestained low molecular 
weight markers (Bio-Rad Laboratories. CA. USA): lane 2, affinity 
purified GST-MF fusion protem of the clone DB-1 by Glutathione 
Sepharose 4B column chromatography as described m the text; lane 
3, affinity purified GST-MF fusion protein of a clone DJ-6; lane 4, 
Affinity purified GST protem: lane 5. Thrombin dlgested GST-MF. 
which orlgmated from the clone DB-1: lane 6. thrombm-dlgested 
GST-MF, which originated from the clone DJ-6; lane 7, the native 
MF protem purllied from the culture supernatant of the S pyogmes 
strain NY-5 as preciously described [13]. Approximately 2 @g protein 
per lane was applied on lanes 2-7 (A) Coomassie blue staming for 
proteins, (B) Western blot with the rabbit antl-MF antiserum. 
3.2. Overexpression and characterization of the recombi- 
nant MF 
Using the cloned MF gene, the mature MF protein 
was recombinantly expressed as a fusion protein with 
GST in E. coli as described in Section 2. On SDS- 
PAGE, the fusion protein and the specimen cleaved by 
thrombin gave protein bands with molecular masses of 
52,000 and 26.000 (Fig. 4A), which correspond to the 
expected values of the GST-MF fusion protein and the 
MF or GST protein. respectively. The cleaved GST-MF 
specimen gave one band, because of the size similarity 
between the MF and GST proteins. The proteins with 
the molecular masses of 52,000 and 26,000 reacted with 
the rabbit anti-MF antiserum on Western blotting. 
whereas, the GST protein alone did not (Fig. 4B). On 
the Ouchterlony double gel diffusion test. the cleaved 
recombinant MF protein corresponding to the mature 
form and the native MF protein secreted from S. p~‘o- 
genes gave a fused precipitine line against the anti-MF 
antiserum (Fig. 5). These results indicate that the re- 
combinant MF has the identical antigenicity to the na- 
tive MF. As shown in Table II, like the native MF, the 
GST-MF fusion protein specimens showed mitogenic 
activity in rabbit peripheral blood lymphocytes in a 
dose-response manner. Moreover, the MF portion 
cleaved by thrombin but not the GST portion had the 
mitogenic activity. The recombinant MF protein fur- 
ther purified by ion-exchange chromatography also 
showed mitogenic activity and the effective dose of the 
recombinant MF seems to be the same as that of the 
native MF secreted from S. pyogenes (data not shown). 
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Fig. 5. Comparison of antigenicity of the recombinant MF and the 
native MF proteins by a micro-double gel immunodiffusion test 
(Ouchterlony’s method). Well 1, thrombin-dtgested GST-MF fusion 
protein of the clone DB-1; well 2. the native MF protein purtfied from 
the culture supernatant of the 5. pyogenes strain NY-5; well 3. throm- 
bin digested GST-MF fusion protein of the clone DJ-6: well 4, GST 
protem alone; well 5, the rabbit anti-MF antiserum. 
4. DISCUSSION 
We have recently reported the finding of a new type 
of MF in the culture supernatant of the S. pyogenes 
strain NY-5 and the determination of its N-terminal 
amino acid sequence [13]. MF shows marked mitogenic 
activity in rabbit peripheral blood lymphocytes. In this 
paper, we report the cloning and expression of the S. 
pq’ogenes MF gene. The nucleotide sequence of the 
cloned MF gene involves one long, open reading frame. 
Its deduced amino acid sequence indicates that the MF 
precursor protein comprises 271 amino acids and re- 
moval of the signal sequence with 43 amino acids results 
in a mature MF protein with 228 amino acids. No cys- 
teine residue is found in the mature MF protein, al- 
though one is found in the signal sequence. Neither the 
nucleotide nor the predicted amino acid sequence of 
MF shows significant homology with that of SPE A. 
SPE B or SPE C. No other similar sequence has been 
reported so far in the GenBank Databases. Using the 
MF genomic DNA cloned, the mature formed MF pro- 
tein was recombinantly expressed in E. coli. We showed 
that its recombinant MF has the same mitogenic activ- 
ity as the native MF secreted from S. pyogenes and the 
identical antigenicity to the native MF. Thus, we con- 
cluded that the gene cloned here is from the authentic 
S. p_vogenes MF gene and is unique. 
It has been reported that the genes for SPE A and 
SPE C reside on temperate bacteriophages [I 8,191. On 
the other hand, the gene for SPE B is chromosomally 
encoded [20] and is described as either identical to [21] 
or related to streptococcal proteinase [3]. The distribu- 
tion of the genes for SPEs have also been reported by 
several investigators [22-241. They described that al- 
most all strains of S. pyogenes have the SPE B gene but 
the genes for SPE A and SPE C were found at a low 
frequency. Hence, in our investigation, the gene for MF 
was detected in almost all strains of S. pyogenes using 
our newly developed PCR detection system, as was the 
SPE B gene (manuscript in preparation). The Southern 
analysis revealed that the restriction map of the genome 
bearing the MF gene among the four S. pyogenes strains 
used here was almost the same (data nto shown). These 
results suggest that the MF gene possibly resides on a 
chromosome. 
McMillian et al. [25] reported the finding of the 
fourth streptococcal pyrogenic exotoxin, termed SPE 
D, and described that there is no antigenic cross-reactiv- 
ity between SPE D and SPE A, SPE B and SPE C. Its 
molecular mass and its isoelectric point (PI) were re- 
ported to be 13,000 and 4.6, respectively. The molecular 
mass of MF is clearly distinct from that of McMillian’s 
SPE D. The exact p1 value of MF has not been exam- 
ined yet but its amino acid composition postulates that 
its p1 value may be relatively higher than 8.0. These 
differences suggest that SPE D is not related to MF. 
Recently, Itoh et al. [26] also reported the cytoplasmic 
membrane-associated mitogenic factor produced by S. 
pyogenes. Its molecular mass was reported to be about 
lO,OOO-15.000, which is different from that of our MF. 
As already described, MF is secreted from S. pyogenes 
Table II 
Mttogemc assay of the native and recombinant MF protein specimens 
Final concentration 13H]Thymidine incorporation 
(protein &ml) (cpm) 
Native MF* 
PBS 
ConA 
GST-MF** 
GST-MF-T*** 
GST-T**** 
PBS 
ConA 
2,356 
783 
236 
78 3 
2.500 
13.200 
4,400 
1.470 
489 
11,700 
3,910 
1.300 
434 
11,800 
3.930 
1.310 
437 
2,500 
23,367 + 1,813 
23,716 ? 1,979 
6.358 f 1.131 
2,873 t 279 
132 2 0.7 
10,696 f 1.765 
30,853 + 257 
9.999 f 531 
2,893 f 345 
131 + 10.7 
42,500 + 13,602 
30.157 f 2,010 
17.239 f 1,488 
3.509 f 685 
512 + 89.1 
513 2 110 
416 ? 73.3 
270 + 31.2 
273 f 87.8 
26.278 ? 2,240 
*The native MF protein purified from the culture supernatant of the 
S pyogenes strain NY-5 
**The recombinant GST-MF fuston protein purified by Glutathione 
Sepharose 4B column chromatography as described in the text. GST- 
MF produced by the E. colr clone DB-1 was used. This clone has a 
single mutation in the coding regton resulting in one amino acid 
change, His”’ to Arg”’ (the number being counted from the N-termt- 
nal of the mature MF). 
***The GST-MF spectmens treated with thrombin. 
****Thrombin was added m the same concentration (10 units, 3260 
NIH unitslmg) to the GST protein spectmen hke the GST-MF speci- 
men was done. 
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cells but is not membrane-associated. Thus, these data 
indicate that Itoh’s factor is also distinct from MF. 
In addition to the mitogenic activity, our preliminary 
data appeared that both the native and recombinant 
MF have heat-resistant nuclease activity (unpublished 
data). Further studies on the biological significance of 
mitogenic, nuclease, and superantigenic activities in MF 
remain to be performed. 
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